Stay updated on Cabozantinib & 13-cisRA in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.

Latest updates to the Cabozantinib & 13-cisRA in Children Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.5.4 has been added, replacing the prior Revision: v3.5.3. This marks a new publication iteration of the page record.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedClinicalTrials.gov’s page footer version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.1%

- Check75 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page update is limited to a revision label change from v3.4.1 to v3.4.2 and does not modify study content, eligibility criteria, contacts, or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib & 13-cisRA in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.